{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:46:30Z","timestamp":1761821190960,"version":"3.32.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.spen.2005.03.003","type":"journal-article","created":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T13:35:14Z","timestamp":1121434514000},"page":"88-96","source":"Crossref","is-referenced-by-count":9,"title":["Antiepileptic Drug Monotherapy: Pediatric Concerns"],"prefix":"10.1016","volume":"12","author":[{"suffix":"III","given":"Joseph E.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis J.","family":"Dlugos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2005.03.003_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-3476(97)70027-1","article-title":"If a first antiepileptic drug fails to control a child\u2019s epilepsy, what are the chances of success with the next drug?","volume":"131","author":"Camfield","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2005.03.003_bib2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1528-1157.2000.tb04604.x","article-title":"How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis","volume":"41","author":"Berg","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib3","series-title":"A Clinical Guide to Epileptic Syndromes and their Treatment","first-page":"114","article-title":"Idiopathic Generalized Epilepsies","year":"2002"},{"key":"10.1016\/j.spen.2005.03.003_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2005.03.003_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-8749.1995.tb11978.x","article-title":"A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy","volume":"37","author":"Verity","year":"1995","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2005.03.003_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(96)90074-4","article-title":"Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy","volume":"347","author":"de Silva","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2005.03.003_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11940-004-0015-6","article-title":"Idiopathic generalized epilepsy","volume":"6","author":"Sullivan","year":"2004","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.spen.2005.03.003_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.34.3.285","article-title":"Juvenile myoclonic epilepsy of Janz","volume":"34","author":"Delgado-Escueta","year":"1984","journal-title":"Neurology"},{"issue":"suppl 4","key":"10.1016\/j.spen.2005.03.003_bib10","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1528-1157.1989.tb05833.x","article-title":"Juvenile myoclonic epilepsy","volume":"304","author":"Penry","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.60.8.1100","article-title":"Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy","volume":"60","author":"Prasad","year":"2003","journal-title":"Arch Neurol"},{"issue":"suppl 7","key":"10.1016\/j.spen.2005.03.003_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1528-1157.44.s7.6.x","article-title":"Clinical trials for treatment of primary generalized epilepsies","volume":"44","author":"Faught","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1684\/j.1950-6945.1999.tb00315.x","article-title":"Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes","volume":"1","author":"Gericke","year":"1999","journal-title":"Epileptic Disord"},{"issue":"suppl 2","key":"10.1016\/j.spen.2005.03.003_bib14","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1528-1157.1987.tb05769.x","article-title":"Monotherapy with valproate in primary generalized epilepsies","volume":"28","author":"Bourgeois","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(01)00271-6","article-title":"A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy","volume":"46","author":"Nieto-Barrera","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2005.03.003_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2005.03.003_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","article-title":"Topiramate, carbamazepine and valproate monotherapy","volume":"107","author":"Privitera","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.spen.2005.03.003_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.51.5.1282","article-title":"A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures","volume":"51","author":"Chadwick","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2005.03.003_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1528-1157.2002.45401.x","article-title":"Gabapentin versus lamotrigine monotherapy","volume":"43","author":"Brodie","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.WNL.0000048200.12663.BC","article-title":"A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy","volume":"60","author":"Gilliam","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2005.03.003_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(97)00025-9","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy","volume":"27","author":"Guerreiro","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2005.03.003_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.0013-9580.2004.40903.x","article-title":"Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures","volume":"45","author":"Coppola","year":"2004","journal-title":"Epilepsia"},{"issue":"suppl 6","key":"10.1016\/j.spen.2005.03.003_bib23","first-page":"163","article-title":"Gabapentin (neurontin) Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes (BECTS)","volume":"39","author":"Bourgeois","year":"1998","journal-title":"Epilepsia"},{"issue":"suppl 2","key":"10.1016\/j.spen.2005.03.003_bib24","first-page":"391","article-title":"Safety and efficacy of oxcarbazepine 1,200 mg\/day in patients with recent-onset partial epilepsy","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2005.03.003_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"issue":"suppl 7","key":"10.1016\/j.spen.2005.03.003_bib26","first-page":"241","article-title":"Topiramate","volume":"43","author":"Arroyo","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0920-1211(01)00311-4","article-title":"Population pharmacokinetics of gabapentin in infants and children","volume":"47","author":"Ouellet","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2005.03.003_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(97)00024-7","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy","volume":"27","author":"Bill","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2005.03.003_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2005.03.003_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0920-1211(96)01013-3","article-title":"A double-blind controlled clinical trial","volume":"26","author":"Christe","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2005.03.003_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1212\/WNL.52.4.681","article-title":"Placebo-controlled studies in neurology","volume":"52","author":"Chadwick","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2005.03.003_bib32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1212\/WNL.55.8.1106","article-title":"Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?","volume":"55","author":"Genton","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2005.03.003_bib33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.0013-9580.2004.19704.x","article-title":"Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies","volume":"45","author":"Gelisse","year":"2004","journal-title":"Epilepsia"},{"issue":"suppl 9","key":"10.1016\/j.spen.2005.03.003_bib34","first-page":"267","article-title":"Topiramate versus valproate in patients with juvenile myoclonic epilepsy","volume":"44","author":"Levisohn","year":"2003","journal-title":"Epilepsia"},{"issue":"suppl 6","key":"10.1016\/j.spen.2005.03.003_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.455005.x","article-title":"The use of antiepileptic drugs\u2014principles and practice","volume":"45","author":"Sander","year":"2004","journal-title":"Epilepsia"},{"issue":"suppl 8","key":"10.1016\/j.spen.2005.03.003_bib36","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1528-1157.2000.tb02944.x","article-title":"Antiepileptic drug interactions","volume":"41","author":"French","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2005.03.003_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2165\/00023210-200115080-00004","article-title":"Harnessing the clinical potential of antiepileptic drug therapy","volume":"15","author":"Perucca","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.spen.2005.03.003_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1059-1311(05)80063-9","article-title":"Rational polypharmacy","volume":"4","author":"Richens","year":"1995","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2005.03.003_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909105000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909105000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T14:27:43Z","timestamp":1735828063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909105000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1071909105000409"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2005.03.003","relation":{},"ISSN":["1071-9091"],"issn-type":[{"type":"print","value":"1071-9091"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}